Bagardi M, Zamboni V, Locatelli C, Galizzi A, Ghilardi S, Brambilla P
Animals (Basel). 2022; 12(2).
PMID: 35049831
PMC: 8773235.
DOI: 10.3390/ani12020209.
Fischer T, Treese N
Med Klin (Munich). 1997; 92(9):546-51.
PMID: 9411203
DOI: 10.1007/BF03044930.
Buchweitz E, Bottalico J, Weiss H
Basic Res Cardiol. 1982; 77(5):552-61.
PMID: 7181834
DOI: 10.1007/BF01907946.
DUCHENE-MARULLAZ P, Gueorguiev G, Kantelip J
Br J Pharmacol. 1982; 77(2):309-17.
PMID: 7139190
PMC: 2044601.
DOI: 10.1111/j.1476-5381.1982.tb09300.x.
Foley D
Pflugers Arch. 1984; 400(1):88-95.
PMID: 6324070
DOI: 10.1007/BF00670541.
Humoral factors and the sodium-potassium pump in low renin hypertension.
Haddy F
Klin Wochenschr. 1982; 60(19):1254-7.
PMID: 6292571
DOI: 10.1007/BF01716733.
Effects of cardiac depression and of anesthesia on the myocardial action of a cardiac glycoside.
Vatner S, Higgins C, Patrick T, Franklin D, Braunwald E
J Clin Invest. 1971; 50(12):2585-95.
PMID: 5129310
PMC: 292208.
DOI: 10.1172/JCI106759.
Electrogenic sodium pump in arterial smooth muscle cells.
Hendrickx H, Casteels R
Pflugers Arch. 1974; 346(4):299-306.
PMID: 4856391
DOI: 10.1007/BF00596185.
Digitalis-induced increase in aortic regurgitation and the contrasting effect of glucagon in the sedated dog.
Hopkins B, Taylor R
J Clin Invest. 1974; 53(6):1716-25.
PMID: 4830233
PMC: 302668.
DOI: 10.1172/JCI107723.
The neurogenic vasoconstrictor effect of digitalis on coronary vascular resistance.
Hamlin N, Willerson J, Garan H, Powell Jr W
J Clin Invest. 1974; 53(1):288-96.
PMID: 4808642
PMC: 301464.
DOI: 10.1172/JCI107549.
The central nervous system as a site of action for the coronary vasoconstrictor effect of digoxin.
Garan H, Smith T, Powell Jr W
J Clin Invest. 1974; 54(6):1365-72.
PMID: 4436438
PMC: 301691.
DOI: 10.1172/JCI107883.
Direct and reflex effects of nitroglycerin on coronary and left ventricular dynamics in conscious dogs.
Vatner S, Higgins C, Milland R, Franklin D
J Clin Invest. 1972; 51(11):2872-82.
PMID: 4404139
PMC: 292436.
DOI: 10.1172/JCI107110.
PY 108-068, a dihydropyridine derivative, and verapamil interact differently with the ouabain effects on the heart and the peripheral circulation.
Hof R, Hof A
Basic Res Cardiol. 1985; 80(1):66-75.
PMID: 3985926
DOI: 10.1007/BF01906745.
Vasoconstriction induced by ouabain in the canine coronary artery: contribution of adrenergic and nonadrenergic responses.
Cooke J, SHEPHERD J, Vanhoutte P
Cardiovasc Drugs Ther. 1988; 2(2):255-63.
PMID: 3154710
DOI: 10.1007/BF00051242.
Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.
Hallaq H, Haupert Jr G
Proc Natl Acad Sci U S A. 1989; 86(24):10080-4.
PMID: 2557617
PMC: 298648.
DOI: 10.1073/pnas.86.24.10080.
How to digitalize and to maintain optimal digoxin levels in congestive heart failure.
Lambert C, Rouleau J
Cardiovasc Drugs Ther. 1989; 2(6):717-26.
PMID: 2488083
DOI: 10.1007/BF00133199.
Effect of ouabain on tone, membrane potential and sodium efflux compared with [3H]ouabain binding in rat resistance vessels.
Aalkjaer C, Mulvany M
J Physiol. 1985; 362:215-31.
PMID: 2410600
PMC: 1192891.
DOI: 10.1113/jphysiol.1985.sp015672.
Digitalis and heart failure: does digitalis really produce beneficial effects through a positive inotropic action?.
Bolognesi R, Tsialtas D, Manca C
Cardiovasc Drugs Ther. 1992; 6(5):459-64.
PMID: 1450089
DOI: 10.1007/BF00055601.
Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure.
Crozier I, Ikram H
Drugs. 1992; 43(5):637-50.
PMID: 1379144
DOI: 10.2165/00003495-199243050-00002.
Blood flow in intact and constricted coronary arteries under the influence of ouabain.
Raberger G, Schutz W, Zimpfer M
Naunyn Schmiedebergs Arch Pharmacol. 1976; 295(1):51-4.
PMID: 1004643
DOI: 10.1007/BF00509772.
